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Abstract: Active travel may be an easily achievable form of physical activity for older people
especially in low- and middle-income countries (LMICs), but there are currently no studies on
how this form of physical activity is associated with a preclinical state of dementia known as mild
cognitive impairment (MCI). Therefore, we aimed to investigate the association between active travel
and MCI among adults aged ≥50 years from six LMICs. Cross-sectional, community-based data
from the World Health Organization’s Study on Global Ageing and Adult Health were analyzed.
The definition of MCI was based on the National Institute on Ageing-Alzheimer’s Association
criteria. Active travel (minutes/week) was assessed with questions of the Global Physical Activity
Questionnaire (GPAQ) and presented in tertiles. Multivariable logistic regression analysis was
conducted to assess the association between active travel and MCI. Data on 32715 people aged
≥50 years (mean age 62.4 years; 52.1% females) were analyzed. Compared to the highest tertile of
active travel, the lowest tertile was associated with 1.33 (95%CI = 1.14–1.54) times higher odds for
MCI overall. This association was particularly pronounced among those aged ≥65 years (OR = 1.70;
95%CI = 1.32–2.19) but active travel was not associated with MCI among those aged 50–64 years.
In conclusion, low levels of active travel were associated with a significantly higher odds of MCI
in adults aged ≥65 years in LMICs. Promoting active travel among people of this age group in
LMICs via tailored interventions and/or country-wide infrastructure investment to provide a safe
environment for active travel may lead to a reduction in MCI and subsequent dementia.
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1. Introduction
The World Health Organisation (WHO) defines dementia as a syndrome in which
there is deterioration in cognitive function (i.e., the ability to process thought) beyond what
might be expected from normal ageing, and this condition may present symptomatically as
memory loss, confusion, disorientation, difficulty speaking or understanding language, and
other symptoms [1]. Dementia is most prevalent among older adults with its prevalence
estimated to be between 5% and 8% among those aged ≥60 years. In addition to the
detrimental impact of dementia on an individual’s quality of life and wellbeing, the care
and support of patients with dementia has wide-ranging consequences for families, health-
care systems, and society as a whole [2]. Since there is no known cure for dementia,
interventions to prevent or delay the emergence of this syndrome are essential.
Mild cognitive impairment (MCI) is a preclinical state of dementia with a high conver-
sion rate to dementia (annual conversion rates ranging from 10% to 15% in clinical samples
and 3.8% to 6.3% in community-based samples) [3–5], and is increasingly being recognized
as an important “target” for the prevention of dementia. One potential correlate of MCI is
that of physical activity. Indeed, not meeting physical activity recommendations is con-
sidered one of the seven main potentially modifiable risk factors for Alzheimer’s Disease
(a predominant form of dementia) and explains approximately 13% (nearly 4.3 million)
of Alzheimer’s Disease cases worldwide [6]. Furthermore, an evolving body of literature
documents significant benefits of long-term, regular physical activity on cognition while it
also reduces dementia risk in people with MCI [7–13].
However, to the best of our knowledge, there are no studies examining the relationship
between active travel (i.e., walking and cycling to and/or from a destination) and MCI.
Active travel is often performed at a moderate intensity [14] and thus, it is possible that this
is an ideal way to ensure physical activity in older adults. Indeed, transport is a necessity
of everyday life, whereas leisure physical activity is possibly an additional burden and is
difficult to sustain long term. Therefore, encouraging active travel is a feasible approach to
increasing levels of moderate physical activity in older adults [15].
Given this, the aim of the present study was to investigate the association between
active travel and MCI in a sample of 32,715 people aged ≥50 years from six low- and middle-
income countries (LMICs). Focusing on LMICs is important as the majority (approximately
60%) of those with dementia reside in this setting [1], while the individual, economic, and
societal burden of dementia is increasing particularly rapidly in LMICs. Furthermore,
levels of physical inactivity [16] are high in these countries, while active travel has been
reported to be a common form of physical activity especially among older adults in low-and
middle-income settings [15].
2. Methods
2.1. The Survey
Data from the Global Ageing and Adult Health Survey (SAGE) were analyzed. These
data are publicly available through http://www.who.int/healthinfo/sage/en/ (accessed
on 18 February 2021). This survey was undertaken in China, Ghana, India, Mexico, Russia,
and South Africa between 2007 and 2010. These countries broadly represent different
geographical locations and levels of socio-economic and demographic transition. Based on
the World Bank classification at the time of the survey, Ghana was the only low-income
country, and China and India were lower middle-income countries although China became
an upper middle-income country in 2010. The remaining countries were upper middle-
income countries.
Details of the survey methodology have been published elsewhere [17]. In brief, in
order to obtain nationally representative samples, a multistage clustered sampling design
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method was used. The sample consisted of adults aged ≥18 years with oversampling
of those aged ≥50 years. Trained interviewers conducted face-to-face interviews using
a standard questionnaire. Standard translation procedures were undertaken to ensure
comparability between countries. If a respondent was unable to undertake the interview
because of limited cognitive function, then a separate questionnaire was administered to
a proxy respondent (e.g., care giver). These individuals were not included in the current
study. The survey response rates were: China 93%; Ghana 81%; India 68%; Mexico 53%;
Russia 83%; and South Africa 75%. Sampling weights were constructed to adjust for
the population structure as reported by the United Nations Statistical Division. Ethical
approval was obtained from the World Health Organization Ethical Review Committee
and local ethics research review boards. Written informed consent was obtained from
all participants.
2.2. Active Travel
Active transport was assessed with questions of the Global Physical Activity Question-
naire (GPAQ) [18]. Participants were asked about the usual way to travel to and from places
(e.g., getting to work, to shopping, to the market, to place of worship etc). The answers for
two questions were used to calculate the minutes spent in active travel per week: (a) In a
typical week, on how many days do you walk or bicycle for at least 10 min continuously
to get to and from places?; (b) How much time would you spend walking or bicycling
for travel on a typical day? Minutes spent in active travel per week was categorized as
low (0–40 min/week), moderate (42–210 min/week), and high (≥217 min/week) based on
tertiles [15,19].
2.3. Mild Cognitive Impairment
MCI was ascertained based on the recommendations of the National Institute on
Aging-Alzheimer’s Association [20]. We applied the identical algorithms used in previous
SAGE publications to identify MCI [21,22]. Briefly, individuals fulfilling all of the following
conditions were considered to have MCI:
(a) Concern about a change in cognition: Individuals who replied ‘bad’ or ‘very bad’
to the question “How would you best describe your memory at present?” and/or those
who answered ‘worse’ to the question “Compared to 12 months ago, would you say your
memory is now better, the same or worse than it was then?” were considered to have
this condition.
(b) Objective evidence of impairment in one or more cognitive domains: was based
on a <−1 SD cut-off after adjustment for level of education and age. Cognitive function
was assessed through the following performance tests: word list immediate and delayed
verbal recall from the Consortium to Establish a Registry for Alzheimer’s Disease [23],
which assessed learning and episodic memory; digit span forward and backwards from
the Weschler Adult Intelligence Scale [24], that evaluated attention and working memory;
and the animal naming task [23], which assessed verbal fluency.
(c) Preservation of independence in functional abilities: was assessed by questions on
self-reported difficulties with basic activities of daily living (ADL) in the past 30 days [25].
Specific questions were: “How much difficulty did you have in getting dressed?” and
“How much difficulty did you have with eating (including cutting up your food)?” The
answer options were none, mild, moderate, severe, and extreme (cannot do). Those who
answered either none, mild, or moderate to both of these questions were considered to
have preservation of independence in functional activities. All other individuals were
deleted from the analysis (935 individuals aged ≥ 50 years).
(d) No dementia: Individuals with a level of cognitive impairment severe enough to
preclude the possibility to undertake the survey were not included in the current study.
J. Clin. Med. 2021, 10, 1243 4 of 11
2.4. Control Variables
The control variables were selected based on past literature and included age, sex,
wealth quintiles based on income, years of education received, setting (rural or urban),
alcohol consumption in the past 30 days, smoking (never, current, past), sleep problems,
anxiety, depression, chronic physical conditions (i.e., diabetes, hypertension, stroke), obe-
sity (body mass index ≥ 30 kg/m2 based on measured weight and height), and other
physical activity (work and leisure) [26,27]. Those having severe or extreme problems
with sleeping in the past 30 days, such as falling asleep, waking up frequently during the
night or waking up too early in the morning, were considered to have sleep problems [28].
Anxiety was defined as having severe or extreme problems with worry or anxiety in the last
30 days [29]. Questions based on the World Mental Health Survey version of the Composite
International Diagnostic Interview [30] were used for the endorsement of past 12-month
DSM-IV depression [31]. Diabetes and stroke were based solely on lifetime self-reported
diagnosis. Hypertension was defined as having at least one of: systolic blood pressure
≥ 140 mmHg; diastolic blood pressure ≥ 90 mmHg; or self-reported diagnosis. Other
physical activity referred to minutes spent per week in moderate-to-vigorous physical
activity in relation to work and leisure activities but not active travel. In line with a previous
publication using the same dataset, work and leisure physical activity were dichotomized
as ≥150 or <150 min/week [19].
2.5. Statistical Analysis
All analyses were done with Stata statistical software version 14.2 (Stata Corp LP,
College Station, TX, USA). The analysis was restricted to those aged ≥50 years. Middle-
aged people were also included in this analysis as cognitive dysfunction can emerge
up to 10 years before a dementia diagnosis [32], and there is increasing evidence that
intervening in mid-life is important [33–36]. Multivariable logistic regression analyses were
used to estimate the association between levels of active travel in tertiles (exposure) and
MCI (outcome). Analyses using the overall sample and age-stratified samples (i.e., 50–64,
≥65 years) were conducted. We also conducted country-wise analysis to assess whether
there is between-country heterogeneity in the association between active travel and MCI.
This analysis was restricted to those aged ≥65 years and used a dichotomous active travel
variable (i.e., low vs. moderate/high) as preliminary analysis showed that the association
between active travel was particularly pronounced in this age group while there were no
significant differences between moderate and high levels of active travel. Furthermore,
we calculated the Higgins’s I2 based on estimates from each country. The Higgins’s I2
represents the degree of heterogeneity that is not explained by sampling error with a value
of <40% often considered as negligible and 40–60% as moderate heterogeneity [37]. A
pooled estimate was obtained by random-effect meta-analysis.
All regression analyses were adjusted for age, sex, wealth, education, setting, alcohol
consumption, smoking, sleep problems, anxiety, depression, diabetes, hypertension, stroke,
obesity, work physical activity, leisure physical activity, and country with the exception
of the country-wise analysis which did not adjust for country. Adjustment for country
was conducted by including dummy variables for each country as in previous SAGE
publications [38,39]. All variables were included in the models as categorical variables
with the exception of age and education (continuous variables). The sample weighting and
the complex study design were taken into account in all analyses with Taylor linearization
methods to obtain nationally representative estimates. Results from the logistic regression
models are presented as odds ratios (ORs) with 95% confidence intervals (95%CIs). The
level of statistical significance was set at p < 0.05.
3. Results
The final sample consisted of a total of 32,715 people aged ≥50 years with preservation
in functional abilities (China n = 12,815; Ghana n = 4201; India n = 6191; Mexico n = 2070;
Russia n = 3766; South Africa n = 3672). The sample characteristics are shown in Table 1.
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The mean age of the sample was 62.4 years and 52.1% were females. The prevalence of MCI
was 14.8% overall. The prevalence of <−1 SD for each cognitive performance test and sever-
ity of activities of daily living for the overall sample and for those with MCI are shown in
Tables S1 and S2, respectively (Supplementary Materials). The median (IQR) of active travel
per week was 140 (0–360) min per week. The prevalence of MCI decreased with increasing
levels of active travel (Figure 1). For example, overall, the prevalence of MCI was 19.8%
among those with low levels of active travel but this decreased to 12.5% among people
with high levels of active travel. After adjustment for potential confounders, compared to
high levels of active travel, low levels were associated with 1.33 (95%CI = 1.14–1.54) times
higher odds for MCI overall (Table 2). The results of the full regression with all covari-
ates are shown in Table S3 (Supplementary Materials) This association was particularly
pronounced among those aged ≥65 years (OR = 1.70; 95%CI = 1.32–2.19) but active travel
was not associated with MCI among those aged 50–64 years. Country-wise associations
between low levels of active travel (vs. moderate or high) among those aged ≥65 years
are shown in Figure 2. Low active travel was positively associated with MCI (i.e., OR > 1)
in all countries with the exception of South Africa. The overall estimate was OR = 1.35
(95%CI = 1.06–1.73). A moderate level of between-country heterogeneity was observed
(I2 = 44.5%).
Table 1. Sample characteristics (overall and by age groups).
Age
Characteristic
Overall 50–64 Years ≥65 Years
(n = 32,715) (n = 19,092) (n = 13,623)
Mild cognitive
impairment No 85.2 86.7 82.6
Yes 14.8 13.3 17.4
Active travel High 31.5 35.2 25.4
Moderate 35.1 36.3 33.0
Low 33.4 28.5 41.6
Age (years) 62.4 (0.2) 56.3 (0.1) 72.6 (0.1)
Sex Male 47.9 49.7 45.0
Female 52.1 50.3 55.0
Wealth Poorest 17.1 14.4 21.7
Poorer 19.0 17.7 21.0
Middle 19.5 19.0 20.4
Richer 21.3 23.6 17.5
Richest 23.1 25.3 19.4
Education (years) 6.0 (0.2) 6.5 (0.2) 5.2 (0.2)
Setting Rural 53.8 56.6 49.4
Urban 46.2 43.4 50.6
Alcohol consumption No 81.3 78.4 86.1
Yes 18.7 21.6 13.9
Smoking Never 58.6 56.3 62.2
Current 34.9 38.3 29.3
Past 6.6 5.4 8.5
Sleep problems No 91.3 93.4 87.8
Yes 8.7 6.6 12.2
Anxiety No 91.9 92.9 90.3
Yes 8.1 7.1 9.7
Depression No 94.0 94.2 93.5
Yes 6.0 5.8 6.5
Diabetes No 93.2 94.2 91.4
Yes 6.8 5.8 8.6
Hypertension No 45.0 50.0 36.6
Yes 55.0 50.0 63.4
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Table 1. Cont.
Age
Characteristic
Overall 50–64 Years ≥65 Years
(n = 32,715) (n = 19,092) (n = 13,623)
Stroke No 97.0 97.9 95.4
Yes 3.0 2.1 4.6
Obesity No 88.5 87.9 89.6
Yes 11.5 12.1 10.4
Work physical activity ≤150 min/week 40.2 33.0 52.7
>150 min/week 59.8 67.0 47.3
Leisure physical activity ≤150 min/week 89.8 89.2 90.7
>150 min/week 10.2 10.8 9.3
Data are % or mean (standard error).
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stroke, obesity, work physical activity, and leisure physical activity. Overall estimate was obtained 
by meta-analysis with random effects. 
4. Discussion 
4.1. Main Findings 
In this large sample of older adults from six LMICs, we found that compared to high 
levels of active travel, low levels were associated with 1.33 times higher odds for MCI. The 
association was strong in those aged ≥65 years but non-significant among middle-aged 
adults (50–64 years). Country-wise analysis showed that the association observed has a 
Figure 1. Prevalence of mild cognitive impairment by levels of active travel.
Table 2. Association between active travel and mild cognitive impairment (outcome) estimated by
multivariable logistic regression.
Overall Age 50–64 Years Age ≥65 Years
OR 95%CI OR 95%CI OR 95%CI
Active travel High 1.00 1.00 1.00
Moderate 0.97 (0.84,1.13) 0.95 (0.79,1.14) 1.04 (0.82,1.31)
Low 1.33 * (1.14,1.54) 1.07 (0.89,1.30) 1.70 * (1.32,2.19)
Abbreviation: OR Odds ratio; CI Confidence interval. Models are adjusted for age, sex, wealth, education, setting,
alcohol consumption, smoking, sleep problems, anxiety, depression, diabetes, hypertension, stroke, obesity, work
physical activity, leisure physical activity, and country. * p < 0.001.
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Figure 2. Country-wise association between low active travel (vs. moderate or high active travel)
among adults aged ≥65 years estimated by multivariable logistic regression. Abbreviation: OR Odds
ratio; CI Confidence interval. Models are adjusted for age, sex, wealth, education, setting, alcohol
consumption, smoking, sleep problems, anxiety, depression, diabetes, hypertension, stroke, obesity,
work physical activity, and leisure physical activity. Overall estimate was obtained by meta-analysis
with random effects.
4. Discussion
4.1. Main Findings
In this large sample of older adults from six LMICs, we found that compared to high
levels of active travel, low levels were associated with 1.33 times higher odds for MCI. The
association was strong in those aged ≥65 years but non-significant among middle-aged
adults (50–64 years). Country-wise analysis showed that the association observed has a
moderate level of between-country heterogeneity. To the best of our knowledge, this is the
first study on active travel and MCI in LMICs.
4.2. Interpretation of the Findings
The results of our study are in line with those of previous studies which have found
associations between physical activity and various forms of cognitive impairment including
dementia [7–13]. There are several plausible pathways that may explain the association
between active travel and MCI. First, participation in physical activity may increase or
maintain cognitive reserve, through increased brain perfusion [9]. Second, participation
in physical activity via active travel aids in the prevention of non-communicable diseases
(e.g., cardiovascular disease and cancer) [40] and certain non-communicable diseases such
as cardiovascular disease are associated with cognitive impairment [41]. Finally, active
travel requires way-finding and potential reliance on cognitive maps using such cognitive
resources may offer some protection against cognitive decline and MCI [42].
It should be noted that in the present study, active travel was associated with MCI
in those aged ≥65 years but not those aged 50–64 years (middle-aged). Previous studies
have also found that the correlates of MCI differ between the middle-aged and older
population [27]. One reason for this discrepancy in findings may be that those aged between
50 and 64 years are at limited risk of MCI in comparison to those aged ≥65 years [43],
while they are also less likely to have chronic conditions, and thus, it is possible that the
beneficial impact of active travel does not emerge until one reaches the age in which the
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risk of MCI is high. However, clearly more future research is needed to understand the
reason for the age-difference.
4.3. Public Health and Policy Implications
Findings from the present study suggest that active travel interventions targeted at
those aged ≥65 years in LMICs may aid in the prevention of MCI and ultimately dementia.
Older adults can be encouraged to partake in active travel by interventions tailored to their
needs, targeted at the most inactive or at those most motivated to change, and delivered
either at the level of the individual or household or through group-based approaches [44].
Moreover, at the country-wide level, active travel may be encouraged in older adults
through the provision of safe places to actively travel such as well-maintained footpaths
and cycle lanes. This is a crucial issue especially in rural settings where the distances
between villages are challenging and the pathways are impracticable especially during the
rainy season [44].
4.4. Strengths and Limitations
The large representative sample of older adults from six LMICs is a clear strength
of the present study. Furthermore, standardized methods to assess MCI was used across
all countries. However, findings must be interpreted in light of the study’s limitations.
First, amount of active travel and some control variables were self-reported potentially
introducing self-report and recall bias into the analyses. For example, older adults with
MCI may be less likely to accurately recall their active travel. Second, analyses were cross-
sectional in design and it is not known whether low levels of active travel precede MCI
or whether MCI precedes low levels of active travel. Since people with MCI may be more
likely to fall, walk unstably, and get lost, this might have made active travel less possible in
these individuals. Third, the control variable “anxiety” was defined as having self-reported
severe or extreme problems with worry or anxiety in the last 30 days. The present analysis
was thus not able to control for specific types of anxiety (e.g., general anxiety disorder).
Fourth, there are currently no standard definitions for MCI especially in population-based
studies. We have used a definition used in previous SAGE studies which was based on the
National Institute on Aging-Alzheimer’s Association. However, it is possible for the results
to have differed if a different definition was used. Relatedly, there is currently no consensus
in terms of the acceptable level of functional impairment that individuals with MCI should
present [45]. The definition of preservation of independence in functional abilities used in
our study was rather conservative. This was done to avoid the omission of MCI cases with
disability not related to their cognitive ability. Finally, because the study was not designed
to generate clinical diagnoses of dementia, some individuals with mild dementia may have
been included in our analytical sample. These individuals may have been classified as MCI
and presented with apathy and social withdrawal which are frequent in some dementia
subtypes. This in turn could have affected the level of physical activity.
5. Conclusions
In this large representative sample of older adults from six LMICs, it was found
that low levels of active travel were associated with a significantly higher odds of MCI
in those aged ≥65 years. Future research of a longitudinal nature is now required to
determine the direction of the association. If confirmed with longitudinal studies, our
study results suggest that promotion of active travel among those aged ≥65 years in LMICs
via tailored interventions and/or country-wide infrastructure investment to provide a safe
environment for active travel may reduce the risk for future MCI/dementia onset.
Supplementary Materials: The following are available online at https://www.mdpi.com/2077-038
3/10/6/1243/s1, Table S1: Prevalence of <-1 SD after adjustment for level of education and age for
each cognitive performance test (overall and among those with mild cognitive impairment), Table S2:
Prevalence of severity of difficulties with activities of daily living (overall and among those with mild
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cognitive impairment), Table S3: Association between active travel or covariates and mild cognitive
impairment (outcome) estimated by multivariable logistic regression.
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